Evidence map›Paper›PMID 34288375›Full record

ArticleJournal of cellular and molecular medicine2021

Microvesicles carrying LRP5 induce macrophage polarization to an anti-inflammatory phenotype.

Aureli Luquero, Gemma Vilahur, Javier Crespo, Lina Badimon, Maria Borrell-Pages

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Reduced Growth and Inflammation in Lrp5Journal of cellular and molecular medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aureli LuqueroCardiovascular Program ICCC, IR-Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.
Gemma VilahurCardiovascular Program ICCC, IR-Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.
Javier CrespoCardiovascular Program ICCC, IR-Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.
Lina BadimonCardiovascular Program ICCC, IR-Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.
Maria Borrell-PagesCardiovascular Program ICCC, IR-Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.ORCID 0000-0002-1759-9756
Instituto de Salud Carlos III · ESHospital de Sant Pau · ES

Funding

RETINAL BLOOD FLOW AND LASER VELOCIMETRYR01EY001303 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI FEKE, GILBERT T. · 1985 to 1991
–
STUDY OF ULTRASONICALLY INDUCED OCULAR DAMAGER01EY001480 · NEI · RIVERSIDE RESEARCH INSTITUTE · PI FELEPPA, ERNEST JOSEPH · 1985 to 1990
–
6 · The paper itself

Abstract

Microvesicles (MV) contribute to cell-to-cell communication through their transported proteins and nucleic acids. MV, released into the extracellular space, exert paracrine regulation by modulating cellular responses after interaction with near and far target cells. MV are released at high concentrations by activated inflammatory cells. Different subtypes of human macrophages have been characterized based on surface epitopes being CD16

Indexed as

Macrophage ActivationPhenotypeAnti-Inflammatory AgentsAtherosclerosisCell DifferentiationCells, CulturedExosomesHumansLow Density Lipoprotein Receptor-Related Protein-5MacrophagesAnti-Inflammatory AgentsLow Density Lipoprotein Receptor-Related Protein-5LRP5 protein, humaninflammationlipidsLRP5macrophagesMV

Identifiers

PMID34288375
PMCPMC8358886
OpenAlexW3185435470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.